Venus Remedies shares KYC update links

1 min read Updated on 22 May 2026, 05:27 AM

Reviewed by

Shriram SScanX News Team

AI Summary

Venus Remedies Limited has informed the stock exchanges about its initiative to raise awareness among shareholders regarding the updation of Know Your Customer (KYC) details. The company shared links to posts on its official social media handles, including Instagram, Facebook, LinkedIn, and X, in compliance with Regulation 30 of the SEBI Listing Obligations Regulations.

*this image is generated using AI for illustrative purposes only.

Venus Remedies Limited has informed the stock exchanges about its initiative to raise awareness among shareholders regarding the updation of Know Your Customer (KYC) details. The company stated that this communication is in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The pharmaceutical company has shared links to posts published on its official social media accounts to facilitate the dissemination of this information. These posts are available on platforms such as Instagram, Facebook, LinkedIn, and X (formerly Twitter). Shareholders have been requested to access these links to understand the requirements and process for updating their KYC details with the company.

Social Media Links

The company provided the following URLs for the specific posts related to the KYC updation awareness campaign:

Platform	Link
Facebook	https://www.facebook.com/share/p/1BVP53h2fu/
Instagram	https://www.instagram.com/p/DYmM_2DIB7M/?utm_source=ig_web_copy_link&igsh=MzRIODBiNWFIZA==
LinkedIn	https://www.linkedin.com/feed/update/urn:li:activity:7463171290812809216
X	https://x.com/remediesvenus/status/2057405435800600705?s=20

The communication was addressed to the National Stock Exchange of India Ltd. and BSE Limited, providing the script codes for the exchanges as VENUSREM and 526953, respectively. The request was signed by Neha, Company Secretary, on behalf of venus remedies .

Historical Stock Returns for Venus Remedies

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+5.00%	+15.39%	+5.67%	+54.37%	+209.25%	+237.30%

What percentage of Venus Remedies' shareholders currently have incomplete or outdated KYC details, and what is the deadline for compliance?

How might non-compliance with KYC updation requirements impact shareholders' ability to receive dividends or participate in future corporate actions by Venus Remedies?

Could SEBI introduce stricter penalties for companies with high rates of non-KYC-compliant shareholders, and how would this affect Venus Remedies' regulatory standing?

Read Next Article

Venus Remedies promoters confirm zero pledged shares in FY26

1 min read Updated on 20 May 2026, 03:59 AM

Reviewed by

Suketu GScanX News Team

Add as a preferred
source on Google

AI Summary

Venus Remedies Limited disclosed that its promoters and promoter group have not pledged or encumbered any shares as of March 31, 2026. The declaration, made under SEBI (SAST) Regulations, confirms no new encumbrances beyond prior disclosures for FY26.

*this image is generated using AI for illustrative purposes only.

Venus Remedies Limited has submitted a yearly disclosure to the stock exchanges confirming that its promoters and promoter group hold no encumbered or pledged shares. The declaration, dated April 4, 2026, was made in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The disclosure covers the financial year ended March 31, 2026. Pawan Chaudhary, Promoter and Managing Director, stated on behalf of the promoter group that they have not made or released any encumbrance of shares, directly or indirectly, other than those already disclosed to the exchanges. He further confirmed that as of March 31, 2026, no equity shares held by the promoters or the promoter group were encumbered or pledged.

The list of promoters and the promoter group included in the disclosure is detailed below:

Category	Name
Promoters
1	Pawan Chaudhary
2	Manu Chaudhary
Promoter Group
3	Peeyush Jain
4	Ashutosh Jain
5	Akshansh Chaudhary
6	Sunev Pharma Solutions Pvt Ltd

The communication was addressed to the National Stock Exchange of India Ltd. and BSE Limited. The company’s compliance officer, Neha, filed the disclosure on behalf of venus remedies .

Historical Stock Returns for Venus Remedies

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+5.00%	+15.39%	+5.67%	+54.37%	+209.25%	+237.30%

How might Venus Remedies' clean pledge record influence institutional investor confidence and potential foreign portfolio investment in the company going forward?

Could the zero-encumbrance status of promoter shares signal upcoming capital raise plans or strategic acquisitions by Venus Remedies in the pharmaceutical sector?

How does Venus Remedies' promoter shareholding stability compare to peers in the mid-cap pharmaceutical space, and what competitive advantages might this provide during market volatility?